Low DCP1A expression was evident in 9 of the other cancer tissues, including bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), prostate adenocarcinoma (PRAD), thyroid carcinoma (THCA), lung squamous cell carcinoma (LUSC) and uterine corpus endometrial carcinoma (UCEC). This evidence concerns the gene DCP1A and bladder transitional cell carcinoma.